JP2017512829A5 - - Google Patents

Download PDF

Info

Publication number
JP2017512829A5
JP2017512829A5 JP2017500412A JP2017500412A JP2017512829A5 JP 2017512829 A5 JP2017512829 A5 JP 2017512829A5 JP 2017500412 A JP2017500412 A JP 2017500412A JP 2017500412 A JP2017500412 A JP 2017500412A JP 2017512829 A5 JP2017512829 A5 JP 2017512829A5
Authority
JP
Japan
Prior art keywords
group
alkyl
aryl
groups
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017500412A
Other languages
English (en)
Japanese (ja)
Other versions
JP6629285B2 (ja
JP2017512829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/055577 external-priority patent/WO2015140178A1/en
Publication of JP2017512829A publication Critical patent/JP2017512829A/ja
Publication of JP2017512829A5 publication Critical patent/JP2017512829A5/ja
Application granted granted Critical
Publication of JP6629285B2 publication Critical patent/JP6629285B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017500412A 2014-03-17 2015-03-17 生体材料及び微生物の保存及び保護のためのグリコペプチド誘導体 Active JP6629285B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14305374.2 2014-03-17
EP14305374 2014-03-17
PCT/EP2015/055577 WO2015140178A1 (en) 2014-03-17 2015-03-17 Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms

Publications (3)

Publication Number Publication Date
JP2017512829A JP2017512829A (ja) 2017-05-25
JP2017512829A5 true JP2017512829A5 (https=) 2018-05-10
JP6629285B2 JP6629285B2 (ja) 2020-01-15

Family

ID=50397079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500412A Active JP6629285B2 (ja) 2014-03-17 2015-03-17 生体材料及び微生物の保存及び保護のためのグリコペプチド誘導体

Country Status (7)

Country Link
US (1) US10100088B2 (https=)
EP (1) EP3119800B9 (https=)
JP (1) JP6629285B2 (https=)
KR (1) KR102335943B1 (https=)
CN (1) CN106459122B (https=)
CA (1) CA2942731C (https=)
WO (1) WO2015140178A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3011449A1 (en) 2016-01-27 2017-08-03 Protokinetix Inc. Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
US10744181B2 (en) 2017-01-30 2020-08-18 Tfchem Glycopeptide derivatives for use in the treatment and/or prevention and/or attenuation of fibrosis diseases
EP3999024A1 (en) * 2019-07-17 2022-05-25 Tfchem Glycopeptides increasing lipid synthesis
KR102274195B1 (ko) 2019-12-04 2021-07-08 고려대학교 산학협력단 자기 조립 화합물을 포함하는 항-동결 조성물
WO2021179081A1 (en) * 2020-03-10 2021-09-16 Protokinetix Inc. Use of anti-aging glycopeptides for treatment of dry eye disease, retinal degenerative diseases, or occular inflammation
CN117222655A (zh) * 2021-01-20 2023-12-12 Tf化学公司 环状糖氨基酸衍生物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117640T3 (es) 1990-01-17 1998-08-16 Univ California Composicion para mejorar la supervivencia de materiales biologicos.
FR2842810B1 (fr) 2002-07-25 2006-01-27 Inst Nat Sciences Appliq Nouveaux composes gem difluores, leur procedes de preparation et leurs applications.
FR2878851B1 (fr) * 2004-12-02 2007-02-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
FR2900154B1 (fr) 2006-04-25 2008-07-04 Inst Nat Sciences Appliq Nouveaux composes c-glycosides gem-difluores derives de la podophyllotoxine, leur preparation et leurs applications.
FR2900405B1 (fr) * 2006-04-27 2013-11-29 Inst Nat Sciences Appliq Nouveaux composes c-glycosides monofluores, leurs procedes de preparation et leurs applications
FR2900656A1 (fr) * 2006-05-03 2007-11-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation notamment pour la preservation de materiaux biologiques
CA2653153A1 (en) 2008-02-07 2009-08-07 University Of Ottawa Antifreeze glycoprotein analogues and uses thereof
NZ613333A (en) 2010-12-22 2015-01-30 Tfchem Derivatives of glyco-cf2-serine and glyco-cf2-threonine

Similar Documents

Publication Publication Date Title
JP2017512829A5 (https=)
RU2403251C2 (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70
CY1123817T1 (el) Μεθοδος για την παρασκευη ενωσεων που ειναι χρησιμες ως αναστολεις sglt
RU2442778C9 (ru) Новые соединения, действующие как ингибиторы erk
RU2018124984A (ru) Контрастные агенты
RU2013132683A (ru) Ингибиторы репликации вирусов гриппа
RU2014140735A (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[1, 5-a]ПИРИМИДИНА, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ СОЕДИНЕНИЯ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
RU2016139352A (ru) Способ получения [(3-гидроксипиридин-2-карбонил)амино]алкановых кислот, сложных эфиров и амидов
ES2653613T3 (es) Procedimiento para la preparación de derivados de carbamato de fenilo
RU2008137526A (ru) Ингибиторы киназы, основанные на гидантоине
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA201391158A1 (ru) Диаминиевые соли фенотиазина и их применение
RU2019115784A (ru) Ингибиторы magl
RU2014145819A (ru) Бициклическое соединение
JP2010520161A5 (https=)
EA200600490A1 (ru) Новые сульфонамиды в качестве средств защиты растений
RU2011129652A (ru) Способ получения активированных сложных эфиров
Önen-Bayram et al. 3-Propionyl-thiazolidine-4-carboxylic acid ethyl esters: a family of antiproliferative thiazolidines
JP2017513915A5 (https=)
JP2007538042A5 (https=)
RU2010139423A (ru) Способ получения оптически активных альфа-аминоацеталей
JP2013245160A (ja) (メタ)アクリル酸誘導体の製造方法
CA2708538A1 (en) Topical compositions containing desthiobiotin and its derivatives and a method of treating skin
EA201070758A1 (ru) Производные азетидинов, их получение и применение в терапии
CA2552195A1 (en) 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level